Goudgaon N, Basha N, Patil S
Indian J Pharm Sci. 2010; 71(6):672-7.
PMID: 20376222
PMC: 2846474.
DOI: 10.4103/0250-474X.59551.
Ey R, Hughes W, Holmes A, Deinhardt F
Trans Am Ophthalmol Soc. 1963; 61:100-12.
PMID: 16693604
PMC: 1316640.
Halford W, Balliet J, Gebhardt B
J Virol. 2004; 78(18):10086-95.
PMID: 15331741
PMC: 515006.
DOI: 10.1128/JVI.78.18.10086-10095.2004.
Davidson S, Evans P
Br J Ophthalmol. 1964; 48:678-83.
PMID: 14249189
PMC: 506041.
DOI: 10.1136/bjo.48.12.678.
Haas R, Maass G
Arch Gesamte Virusforsch. 1964; 14:567-82.
PMID: 14247354
THE RIDDLE OF UVEITIS.
James D
Postgrad Med J. 1964; 40:686-91.
PMID: 14227660
PMC: 2482817.
DOI: 10.1136/pgmj.40.470.686.
EFFECTS OF 5-IODO-2' -DEOXYURIDINE AND PHENYLMERCURIC DINAPHTHYLMETHANE DISULPHONATE ON HERPES GENITALIS.
HUTFIELD D
Br J Vener Dis. 1964; 40:210-2.
PMID: 14210489
PMC: 1047654.
DOI: 10.1136/sti.40.3.210.
ATTEMPTED TREATMENT OF TRACHOMA WITH IDOXURIDINE.
Sowa S, Sowa J
Br Med J. 1964; 2(5415):989.
PMID: 14185690
PMC: 1816571.
DOI: 10.1136/bmj.2.5415.989.
TREATMENT OF NON-GONOCOCCAL URETHRITIS WITH 5-IODO-2'-DEOXYURIDINE.
HUTFIELD D
Br J Vener Dis. 1964; 40:146-7.
PMID: 14169944
PMC: 1047638.
DOI: 10.1136/sti.40.2.146.
Treatment of herpes simplex with 5-iodo-2'-deoxyuridine.
HALL-SMITH S, Corrigan M, Gilkes M
Br Med J. 1962; 2(5318):1515-6.
PMID: 13952144
PMC: 1927045.
DOI: 10.1136/bmj.2.5318.1515.
Treatment of dendritic corneal ulceration.
Corrigan M, Gilkes M, ST CLAIR ROBERTS D
Br Med J. 1962; 2(5300):304-5.
PMID: 13881470
PMC: 1925568.
DOI: 10.1136/bmj.2.5300.304.
Alpha/Beta interferon and gamma interferon synergize to inhibit the replication of herpes simplex virus type 1.
Sainz Jr B, Halford W
J Virol. 2002; 76(22):11541-50.
PMID: 12388715
PMC: 136787.
DOI: 10.1128/jvi.76.22.11541-11550.2002.
The treatment of herpes simplex virus epithelial keratitis.
Wilhelmus K
Trans Am Ophthalmol Soc. 2001; 98:505-32.
PMID: 11190039
PMC: 1298240.
Immunopathogenesis of herpetic ocular disease.
Thomas J, Rouse B
Immunol Res. 1997; 16(4):375-86.
PMID: 9439761
DOI: 10.1007/BF02786400.
Evaluation of a peptidomimetic ribonucleotide reductase inhibitor with a murine model of herpes simplex virus type 1 ocular disease.
Brandt C, Spencer B, Imesch P, Garneau M, Deziel R
Antimicrob Agents Chemother. 1996; 40(5):1078-84.
PMID: 8723444
PMC: 163269.
DOI: 10.1128/AAC.40.5.1078.
Quantitation of herpes simplex virus type 1 shed in preocular tear film of rabbits treated with acyclovir.
GREEN M, Dunkel E, Morris B
Antimicrob Agents Chemother. 1981; 20(5):580-2.
PMID: 6275777
PMC: 181754.
DOI: 10.1128/AAC.20.5.580.
5'-Amino-5'-deoxythymidine: synthesis, specific phosphorylation by herpesvirus thymidine kinase, and stability to pH of the enzymically formed diphosphate derivative.
Chen M, Shiau G, Prusoff W
Antimicrob Agents Chemother. 1980; 18(3):433-6.
PMID: 6252834
PMC: 284018.
DOI: 10.1128/AAC.18.3.433.
Use of 5-iodo-2-deoxyuridine (Idoxuridine) in cutaneous herpes simplex.
KEY J
Calif Med. 1965; 103(4):247-8.
PMID: 5318352
PMC: 1515933.
The problem or oral ulcerations in general practice with special reference to herpetic herpetiform lesions.
Fox E
J R Coll Gen Pract. 1970; 19(93):191-200.
PMID: 4911700
PMC: 2237279.
Herpes simplex virus skin infection in hairless mice: treatment with antiviral compounds.
Klein R, Friedman-Kien A, Brady E
Antimicrob Agents Chemother. 1974; 5(3):318-22.
PMID: 4840439
PMC: 428967.
DOI: 10.1128/AAC.5.3.318.
